ALG1L11P

Across TCGA pan-cancer cohorts, ALG1L11P RNA is linked to patient survival in 16 of 34 cancer types, making it the most broadly survival-associated ALG1L11P data layer.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher ALG1L11P RNA is associated with better overall survival. In most high-consensus cancer types, elevated ALG1L11P expression acts as an unfavorable survival marker, although some lineages such as BLCA and HNSC show a favorable association.

BLCA, LUAD, and LGG are the cancer types where ALG1L11P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	OS	Median	All	0.568	0.381	.004	61	view →
LUAD	OS	Tertile	III,IV	0.379	0.575	.010	51	view →
LGG	DFS	Median	All	0.777	0.887	<.001	41	view →
UCEC	DFS	Tertile	II,III,IV	0.629	0.782	.011	36	view →
LIHC	OS	Tertile	III,IV	0.051	0.738	<.001	36	view →
HNSC	DFS	Tertile	IV	0.431	0.286	.020	31	view →
PAAD	OS	Quartile	All	0.599	0.332	.003	20	view →
LUSC	OS	Tertile	IV	0.001	0.651	.025	19	view →
THCA	OS	Median	II,III,IV	0.930	0.988	.026	17	view →
BRCA	OS	Median	III,IV	0.887	0.772	.007	12	view →
THYM	DFS	Median	III,IV	1.000	0.368	.001	9	view →
READ	DFS	Tertile	IV	0.095	0.697	.014	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 16 lineages.

ALG1L11P–BLCA (OS)

Open the BLCA breakdown →